Finding the Right Dose: Using Patient-Reported Data in Early Phase Clinical Trials

Janet Freeman-Daily will lead a discussion and Q&A, following panel presentations by Dr. Bellinda King-Kallimanis (LUNGevity), Anne Loeser (PCDI, Patient Centered Dosing Initiative), Janice Cowden (PCDI), and Lee Jones (Patient/Survivor).

Educational Objectives:

• Discover how drug makers have traditionally determined the dose for cancer drugs during early clinical trials
• Find out how the FDA is planning to optimize the calculation of the dose for cancer drugs in the era of targeted therapies
• Hear about the potential impact that patient experience data could have in optimizing the dose
• Learn about the role patient research advocates can play in these discussions

Live interpretation will be offered in the below languages:

• Chinese (Mandarin)
• French
• German
• Greek
• Japanese
• Spanish (Latin America/neutral)

Please reach out to advocacy@iaslc.org with any questions. We look forward to seeing you on August 24!